Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
FORMULATION CONTAINING EMRICASAN
Document Type and Number:
WIPO Patent Application WO/2020/004652
Kind Code:
A1
Abstract:
The present disclosure provides a formulation having improved solubility and/or stability of emricasan. In one embodiment, the present disclosure provides a formulation containing (i) emricasan or a derivative thereof, or a pharmaceutically acceptable salt thereof, or a solvate thereof, (ii) a nonionic surfactant including a polyoxyethylene group, and (iii) a buffering agent that maintains the pH at about 4.5 to about 8.5. The present disclosure also provides a composition in the form of powder for preparing such a formulation at the time of use.

Inventors:
KOIZUMI NORIKO (JP)
OKUMURA NAOKI (JP)
Application Number:
PCT/JP2019/025945
Publication Date:
January 02, 2020
Filing Date:
June 28, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
THE DOSHISHA (JP)
International Classes:
A61K38/05; A61K9/08; A61K9/14; A61K47/02; A61K47/14; A61K47/26; A61K47/34; A61P27/02
Domestic Patent References:
WO2017110094A12017-06-29
WO2017129585A12017-08-03
WO2017222370A12017-12-28
WO2017110094A12017-06-29
Foreign References:
JP2017515854A2017-06-15
JP2017507165A2017-03-16
JP2015501828A2015-01-19
JP2018125234A2018-08-09
Other References:
EDITED BY JAPAN PHARMACEUTICAL ADDITIVES ASSOCIATION: "Passages, Pharmaceutical additives encyclopedia 2016", PHARMACEUTICAL ADDITIVES ENCYCLOPEDIA 2016, 2016, pages 155, 536, 537, XP009524926, ISBN: 978-4-8408-1329-7
Attorney, Agent or Firm:
YAMAMOTO Shusaku et al. (JP)
Download PDF: